NOVEL GUANOSINE TRIPHOSPHATE-BINDING PROTEIN-COUPLED RECEPTOR PLACE6002312, ITS GENE, AND PRODUCTION AND USES THEREOF
The clone PLACE6002312 having a structure characteristic of G protein-coupled receptor was isolated from a human placental full-length cDNA library prepared by the oligo-capping method. Database search revealed that PLACE6002312 had the highest homology to HISTAMINE H2 RECEPTOR. Analysis for the expression of PLACE6002312 gene in human tissues revealed that the gene was expressed in various tissues, such as heart, liver, and ovary. In addition, histamine was found to be one of ligands for PLACE 6002312 by ligand-binding assay. Furthermore, a full-length cDNA for the mouse homolog of PLACE6002312 was isolated and the deduced amino acid sequence was revealed to comprise a structure characteristic of G protein-coupled receptor. PLACE6002312 can be used to screen for agonists and antagonists useful as pharmaceuticals and to diagnose various diseases caused by the abnormal activity or expression of the polypeptide.
1 - 11 . (canceled)
12 : A method for identifying an agonist of polypeptide, which comprises:
(a) contacting a cell expressing the polypeptide with a candidate compound; and
(b) determining whether or not the candidate compound induces the generation of a signal that can be used as an indicator for the activation of the polypeptide, wherein the polypeptide is expressed by one of the following polynucleotides
(a) a polynucleotide which encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 2 or 20;
(b) a polynucleotide which comprises a coding region of the nucleotide sequence of SEQ ID NO: 1 or 19;
(c) a polynucleotide which encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 2 or 20 wherein one or more amino acids are substituted, deleted, added, and/or inserted; and
(d) a polynucleotide which hybridizes to a DNA comprising the nucleotide sequence of SEQ ID NO: 1 or 19 under a stringent condition.
13 : A method for identifying an antagonist of a polypeptide, which comprises:
(a) contacting an agonist of the polypeptide with a cell expressing the polypeptide in the presence of a candidate compound; and
(b) determining whether or not a signal as an indicator for the activation of the polypeptide is attenuated as compared with the case in the absence of the candidate compound, wherein the polypeptide is expressed by one of the following polynucleotides
(a) a polynucleotide which encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 2 or 20;
(b) a polynucleotide which comprises a coding region of the nucleotide sequence of SEQ ID NO: 1 or 19;
(c) a polynucleotide which encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 2 or 20 wherein one or more amino acids are substituted, deleted, added, and/or inserted; and
(d) a polynucleotide which hybridizes to a DNA comprising the nucleotide sequence of SEQ ID NO: 1 or 19 under a stringent condition.
14 - 22 . (canceled)
23 . The method of claim 12 , wherein the polypeptide is expressed by a polynucleotide which encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 2.
24 . The method of claim 13 , wherein the polypeptide is expressed by a polynucleotide which encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 2.
25 . The method of claim 12 , wherein the polypeptide comprises SEQ ID NO:2.
26 . The method of claim 13 , wherein the polypeptide comprises SEQ ID NO:2.